Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing sugarBEAT® as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed to provide persons with diabetes and pre-diabetics with an Ambulatory Glucose Profile (AGP) as a superior metric to better manage their glucose levels as compared to an HbA1c reading. SugarBEAT® consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings at five-minute intervals for periods of up to 24 hours. SugarBEAT® should significantly expand the use of adjunctive CGM among people with diabetes, given it is more non-invasive (not requiring the insertion of a sensor into skin), affordable, and flexible than competitor CGMs.
TapImmune Inc. (NASDAQ: TPIV) is a leader in the development of novel immunotherapies for cancer, with multiple Phase 2 and Phase 1b/2 clinical studies currently ongoing for the treatment of ovarian and breast cancer. Its stock is surging in response to a steady stream of good news:
In March 2018, TapImmune published positive safety results in a Phase 1 trial for ovarian and breast cancer for its lead vaccine candidate TPIV200. This vaccine has been fast-tracked by the FDA with an orphan drug designation. This will allow more frequent interaction with the FDA and the possibility of accelerated review.
Immuron Limited (NASDAQ: IMRN) is an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases.
Here are some reasons 2018 has been so good for IMRN:
Immuron Product Traveler American Package
In March 2018, Immuron reported positive top line Phase 2 results in a NASH clinical study. This was an extremely welcome development, as NASH therapies are estimated to become a $40 billion global market by 2025. The company also received a European patent grant for NASH treatment.
The Dorado, Puerto Rico location of Green Spirit RX, a growing chain of medical marijuana dispensaries in Puerto Rico owned and operated by GSRX Industries (OTCQB: GSRX), was named one of the Caribbean’s best by Leafly, the world’s leading cannabis website. With 15 million monthly visitors and 40 million page views across its website and mobile applications, Leafly regularly publishes user ratings and reviews for different cannabis strains and cannabis dispensaries.
Why It Matters: In the October 10 feature entitled “Caribbean Dispensaries: Puerto Rico’s and Jamaica’s Best Stops,” Leafly reports that “With rotating deals and a solid 5-star rating, Green Spirit RX in Dorado manages high-quality products with customer care. Load up at this dispensary before catching a movie at the Caribbean Cinemas of Dorado next door.” The Leafly feature recommends a total of three dispensaries in Jamaica and five in Puerto Rico.
GSRX’s Dorado Green Spirit RX medicinal cannabis dispensary is located at the Paseo del Plata Shopping Center, Building No. 3, P.R. 696, int. José Efrón Avenue. The dispensary opened in April of this year, and is one of four Green Spirit RX dispensaries GSRX operates in Puerto Rico. Dorado, a popular tourist destination, is home to numerous golf courses, beaches and luxury hotels, including Dorado Beach – A Ritz-Carlton Reserve, the Caribbean’s only 2017 Forbes Five-Star Hotel and Spa award winner. Dorado is also home to upscale neighborhoods and a picturesque central square. Dorado Beach East is one of the islands most sought-after luxury residential areas, and home to some of Puerto Rico’s most exclusive neighborhoods and multi-million-dollar residences.
What’s Next: GSRX previously announced it intends to report its Q3 results on October 22. With operations continuing to expand throughout the quarter, the Company is expected to show solid growth over Q2.
Longer-term, GSRX, led by former Macy’s Midwest Chairman & CEO Les Ball, is well-positioned for success in the rapidly evolving market for medical and adult-use marijuana in the U.S.
Despite its strong position, shares of the company have lagged the broader bull market in marijuana stocks. This is not uncommon for newer issues that haven’t reached Wall Street’s radar yet. Eventually, with continued performance and growth, we believe the shares will catch the attention of bigger investors, allowing the company to trade more in line with its peers.
Disclosure
GSRX Industries (OTCQB: GSRX) is a client of RedChip Companies. RedChip Companies, Inc. received 1,000,000 registered shares of GSRX for consulting services and 50,000 shares for investor awareness services. Be advised RedChip intends to sell some or all of its shares at any time, including when you are buying.
Spectrum Global Solutions (OTC: SGSI), a single-source provider of end-to-end next-generation wireless and wireline network services and staffing solutions to the service provider (carrier) and corporate enterprise markets, secured a $5 Million revolving asset based line of credit with Heritage Bank of Commerce last week. This facility is an accounts receivable line of credit that will support the growth of our ADEX Corporation subsidiary.
Why it matters: SGSI has been growing rapidly this year, generating revenue of $15.3 million in the first six months of the fiscal year. Based on public comments from management, SGSI is currently operating at a $35 million annual revenue run rate, yet the stock trades for just a fraction of revenue, presenting big upside for investors. With this credit facility now in place, SGSI will have additional flexibility in servicing its growing backlog of contract awards, and with the massive growth in spending in the telecom industry, growth is unlikely to slow down for the foreseeable future
Key Quote: “Adding a revolving bank credit facility to our financial structure is another tangible sign of our growth as a company and a third-party vote of confidence in our future. Access to reasonable bank interest rates and commercial paper insures our ability to maintain our growth, at a reduced cost and without interruption.” – Roger Ponder, CEO
Watch latest video on Spectrum Global Solutions to learn why this stock could trade at significantly higher levels.
Disclosure
Spectrum Global Solutions (OTC: SGSI) is a client of RedChip Companies, Inc. SGSI agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.
PHI Group, Inc. (www.phiglobal.com) (OTCQB: PHIL), a U.S. diversified holding company focused on mergers and acquisitions and investments in select industries and special situations, today announced the availability of a new corporate video that highlights PHI Group’s strengths and market opportunities in Vietnam.
Why it matters: The Corporate video focuses on Phi Group’s deep understanding of the economy and business opportunities in Vietnam, particularly in the plastics film industry. Yesterday the Company announced the completion of the acquisition of Vinafilms Joint Stock Company, a fast-growing manufacturer of plastics film products in Vietnam with 2017 revenue of $25M.
Back Story: PHIL is a fast-growing holding company implementing an acquisition model to acquire established and revenue-generating private companies that PHIL management believes will substantially increase shareholder value. The Company recently announced an agreement to acquire a majority interest in Vinafilms JSC, a Vietnamese plastic manufacturing company (www.vinafilms.com.vn), in order to create a platform to consolidate other businesses in the same industry.
Management expects combined revenues from these operations to surpass $150 million by 2019. The acquisition of Vinafilms JSC on September 30, 2018, subject to full compliance, should enable PHIL to uplist to the NASDAQ in the near future.
Disclosure
PHI Group Inc. (OTCQB: PHIL) is a client of RedChip Companies, Inc. PHIL agreed to pay RedChip Companies, Inc. a monthly cash fee for 4 months of investor awareness services.
Marijuana stocks rallied Monday after one of the largest Canadian cannabis companies announced that it has agreed to acquire a U.S.-based hemp company.
Canopy Growth (NYSE: CGC) told investors its purchase of Evergreen, Colorado-based ebbu will "complement and accelerate" its ambitions to expand into new types of consumer products.
"Intellectual property and research and development advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities," Canopy Growth said in a press release.
Shares of Canopy Growth, which trade on the New York Stock Exchange, rallied 9 percent following the news. Tilray, the largest player in the space, saw its stock rise 7.1 percent on the Nasdaq; Aurora Cannabis climbed 7.5 percent in Toronto.
Ebbu specializes in the purification and study of cannabinoids for product development, wholesale and research purposes, according to its website. It also uses patented plant genetics to maximize cannabinoid output by "boosting in-plant cannabinoid production and creating rare-cannabinoid-specific plants."
Canopy was the first publicly traded cannabis company in North America in 2014 under the leadership of co-CEO Bruce Linton. The company markets medical marijuana products — including flowers and oils — in Canada, Germany and the Czech Republic and recently tightened its relationship with Corona brewer Constellation Brands.
The beer brewer is investing about $4 billion into the Canadian marijuana grower in its efforts to broaden its strategic portfolio as beer consumption in the United States declines.
And while the upside for Constellation appears obvious, the benefit is two-fold. A check from one of the world's largest brewers is a welcome influx of capital for a handful of cannabis companies whose success will likely be defined by their ability to raise capital and scale production.
Recreational use of cannabis in Canada becomes legal Wednesday, though each of the country's 10 provinces will be able to regulate the market within their jurisdiction independent of Ottawa.
The second-largest U.S. ride-sharing company's valuation could top $15 billion in the public markets, said the person, who asked not to be named because the discussions are private. Lyft raised $600 million in Series I funding earlier this year, giving it a value of $15.1 billion.
Lyft sales got a bump last year as Uber struggled with a "#deleteUber" campaign after a series of company scandals and missteps. Since then, Uber replaced CEO and founder Travis Kalanick with Dara Khosrowshahi, who has worked hard to restore Uber's public image.
Interpace Diagnostics Group, Inc. (IDXG) announced that the Company presented new data at the 88th Annual Meeting of the American Thyroid Association (ATA) on Friday, October 5th supporting its molecular tests for thyroid cancer. The new interim data, spanning over 300 samples from a two-year, “real world,” retrospective study, highlighted the clinical utility of Interpace’s ThyGenX® thyroid oncogene panel in combination with its micro-RNA classifier, ThyraMIR®. J. Woody Sistrunk, MD, founder of the Jackson Endocrine and Thyroid Clinic in Jackson, MS, presented the results during a live poster session and as part of the Product Expo Theater presentation. Currently, the data submission process for publication is underway and the complete results will be made available at that time.
Key Quote: Jack Stover, President and CEO of Interpace Diagnostics, stated, “We are pleased with the favorable response we have received since this data was presented.” He continued, “Having real-world data on how our products positively impact patient care should be well received by practitioners and further validates our novel combination thyroid test.”
Quote of the Week
"Work hard, be a long-term thinker, develop tenacity and remember nothing happens without taking calculated risks."
Phil Sassower, Chairman Phoenix Group-Microcap Superstar
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov.
